Search
Regulatory Story
Company Consort Medical PLC
TIDM CSRT
Headline Director/PDMR Shareholding
Released 07:00 06-Aug-2019
Number 9671H07

RNS Number : 9671H
Consort Medical PLC
06 August 2019
 

Consort Medical plc

Director Shareholding

6 August 2019

Consort Medical plc (the 'Company') announces that Chris Brinsmead, Chair purchased 1,000 ordinary 10p shares at an aggregated price of £7.3190 per share on 2 August 2019. Following this transaction Mr Brinsmead holds 6,000 ordinary shares in the Company.

The Notification of Dealing Form set out below is provided in accordance with the requirements of the Market Abuse Regulation.

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Chris Brinsmead

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Chair

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Consort Medical plc

 

b)

 

LEI

 

 

2138001TBP74FD66QT38

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 10p each



Identification code

ISIN: GB0000946276



b)

 

Nature of the transaction

 

 

Acquisition

c)

 

Price(s) and volume(s)

 

 

 

 


 

Price(s)

Volume(s)

 


 

£7.3190

1,000

 


 



 


 



 


 

 

 

 

d)

 

Aggregated information




- Aggregated volume

1,000



- Price

£7.3190



e)

 

Date of the transaction

 

 

2019-08-02

f)

 

Place of the transaction

 

 

London Stock Exchange XLON

 

Enquiries:  Andrew Jackson, Company Secretary 01442 867920


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHQELFBKVFXBBF
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.